Zealand Pharma A/S (ZEAL): IPOs News

ZEAL – Prices 4.375 mln share IPO (upsized from 3.9 mln prior) at $17.87 per ADS, below the expected price of $19.25.

Key Facts Surrounding This News Item

  • ZEAL had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Zealand Pharma A/S (ZEAL)

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark. View our full ZEAL ticker page with ratings, news, and more.

Try StockNews.com Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

ZEAL at a Glance

ZEAL Current POWR Rating™
Overall POWR Rating™
ZEAL Current Price $15.71 3.70%
More ZEAL Ratings, Data, and News

ZEAL Price Reaction

The day of this event (Aug. 9, 2017)
ZEAL Closing Price$17.82 N/A%
ZEAL Volume1,715,000
N/A% from avg
Leading up to this event
ZEAL 1-mo returnN/A%
After this event
ZEAL 1-day returnN/A%
ZEAL 3-day returnN/A%
ZEAL 5-day returnN/A%

ZEAL Price Chart

More Zealand Pharma A/S (ZEAL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ZEAL News
Page generated in 1.434 seconds.